Hindustan Agrigenetics Receives Request for Public Shareholder Reclassification to Promoter Category

1 min read     Updated on 30 Sept 2025, 07:02 PM
scanx
Reviewed by
Jubin VergheseScanX News Team
Overview

Hindustan Agrigenetics Limited has received a request from a public shareholder seeking reclassification to the Promoter category. The company will follow regulatory procedures for this process. Simultaneously, the company announced board changes, appointing Rajendra Naniwadekar as Additional Non-Executive Non-Independent Director, and Shashank Vaidya and Punukollu Kodanda Rambabu as Non-Executive Independent Directors for 3-year terms.

20784755

*this image is generated using AI for illustrative purposes only.

Hindustan Agrigenetics Limited, a company listed on the BSE, has announced a significant development in its shareholding structure. The company has received a request from a public shareholder seeking reclassification to the Promoter category, as disclosed in a regulatory filing on September 30, 2025.

Key Details of the Reclassification Request

  • The request was received on September 30, 2025.
  • The company will undertake necessary steps to comply with regulatory requirements for this reclassification process.
  • Director Pritam Kapur communicated this development to BSE Limited's Listing Compliance Monitoring Cell.

Regulatory Compliance

The company stated that it will follow the procedures outlined in Regulation 31A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which governs the reclassification of shareholders from one category to another.

Recent Board Changes

In a separate but related development, Hindustan Agrigenetics Limited also announced significant changes to its Board of Directors on the same day:

  1. Rajendra Naniwadekar appointed as an Additional Non-Executive Non-Independent Director.
  2. Shashank Vaidya appointed as a Non-Executive Independent Director for a 3-year term.
  3. Punukollu Kodanda Rambabu appointed as a Non-Executive Independent Director for a 3-year term.

Implications of the Reclassification

The reclassification request, if approved, could potentially alter the company's shareholding pattern and influence its governance structure. Shareholders and market observers will be closely watching the outcome of this process and its impact on the company's future direction.

Hindustan Agrigenetics Limited, with its registered office in New Delhi, operates in the agricultural sector.

Hindustan Agrigenetics' Independent Directors Deem Rs. 54 per Share Open Offer Fair

1 min read     Updated on 28 Aug 2025, 12:37 PM
scanx
Reviewed by
Jubin VergheseScanX News Team
Overview

The Committee of Independent Directors of Hindustan Agrigenetics Limited (HAL) has concluded that the open offer by Mr. Rajendra Naniwadekar is fair and reasonable. The offer aims to acquire up to 11,44,052 equity shares, representing 26% of the company's voting share capital, at Rs. 54.00 per share. The committee's decision was based on a review of the Public Announcement, Detailed Public Statement, and Letter of Offer. This development is significant for shareholders considering the potential change in company ownership.

17910445

*this image is generated using AI for illustrative purposes only.

Hindustan Agrigenetics Limited (HAL) has announced that its Committee of Independent Directors has concluded the open offer by Mr. Rajendra Naniwadekar to be fair and reasonable. This development marks a significant milestone in the potential ownership change of the agribusiness company.

Open Offer Details

The open offer, initiated by Mr. Rajendra Naniwadekar (referred to as "the Acquirer"), aims to acquire up to 11,44,052 equity shares of Hindustan Agrigenetics Limited. Key points of the offer include:

  • Offer Price: Rs. 54.00 per share
  • Face Value: Rs. 10.00 per share
  • Target Acquisition: 26% of the company's fully paid-up voting share capital

Timeline of Events

The Committee of Independent Directors reached their decision after a thorough review of the following documents:

  1. Public Announcement dated January 13, 2025
  2. Detailed Public Statement published on January 20, 2025
  3. Letter of Offer dated August 25, 2025

Committee's Decision

In a meeting held on August 28, 2025, the Committee of Independent Directors discussed, analyzed, and reviewed the open offer. Their conclusion that the offer is "fair and reasonable" provides a positive signal to shareholders considering the proposal.

Company Information

Hindustan Agrigenetics Limited, with its registered office in New Delhi, operates under the CIN: L01119DL1990PLC040979. The company's shares are listed on the Bombay Stock Exchange (BSE).

Implications for Shareholders

This endorsement by the Independent Directors committee is a crucial factor for shareholders to consider. While the committee's opinion is that the offer is fair, shareholders should conduct their own assessment based on their individual financial situations and investment goals before making a decision.

Next Steps

Shareholders of Hindustan Agrigenetics Limited should keep an eye out for further communications regarding the open offer process, including important dates and procedures for participating in the offer, if they choose to do so.

The outcome of this open offer could potentially lead to a significant change in the ownership structure of Hindustan Agrigenetics Limited, which may have implications for the company's future direction and strategy.

More News on Hindustan Agrigenetics
Explore Other Articles